Evidence map›Paper›PMID 41122814›Full record

ReviewJournal of internal medicine2025

Ignoring the planet: A critical blind spot for research on ageing.

Paul Shiels, Ognian Neytchev, Gillian Borland, Polina Germushkina, Richard Johnson, Peter Stenvinkel, Tina Woods

Abstract readReview
In one paragraph

Review in Journal of internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paul ShielsGlasgow Geroscience Group, School of Molecular Biosciences, MVLS, University of Glasgow, Glasgow, UK.ORCID 0000-0002-7577-9843
Ognian NeytchevGlasgow Geroscience Group, School of Molecular Biosciences, MVLS, University of Glasgow, Glasgow, UK.ORCID 0000-0002-9510-2135
Gillian BorlandGlasgow Geroscience Group, School of Molecular Biosciences, MVLS, University of Glasgow, Glasgow, UK.
Polina GermushkinaGlasgow Geroscience Group, School of Molecular Biosciences, MVLS, University of Glasgow, Glasgow, UK.
Richard JohnsonThe Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.ORCID 0000-0003-3312-8193
Peter StenvinkelDepartment of Clinical Science, Intervention and Technology, Division of Renal Medicine, Karolinska Institutet, Huddinge, Sweden.
Tina WoodsCollider Health, London, UK.

Funding

Revalesio (USA)
6 · The paper itself

Abstract

Although research on ageing has largely concentrated on understanding the fundamental biology of the ageing process and devising pharmaceutical interventions in order to slow it down, increasing evidence has underscored the crucial role of environmental inputs across the life course and across generations, in shaping both individual and intergenerational trajectories of age-related health. These include nutrition, air pollution, social deprivation, lifestyle factors, climate change and exposure to environmental toxins, including microplastics and nanoplastics. The development of the concept of the exposome of ageing and the emergence of the new field of 'exposomics' have identified a blind spot, in particular, for geroscience. The impact of the exposome affecting human 'healthspan' (i.e., years lived in good health), extending across generations, is significant and yet under-explored in research. As such, it is under-appreciated that the declining health of the planet will have intergenerational ripple effects, epigenetically priming adverse health in future generations. We discuss the capacity to manipulate our exposome to mitigate against such effects, by addressing root causes, rather than symptoms, of both physiological and planetary dysregulation, dysfunction and decay. We propose a systems-based framework that reconnects research on ageing with exposomics and planetary ecology, creating a new field of 'ecological or exposome pharmacology', harnessing the activity of Nrf2 as a senotherapeutic intervention to improve trans- and intergenerational physiology in the face of declining planetary health.

Indexed as

AgingEnvironmental ExposureExposomeClimate ChangeHumansageingepigeneticsexposomegeroscienceplanetary health

Identifiers

PMID41122814
PMCPMC12617485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.